Dynorphin expression, processing and receptors in the alveolar macrophages, cancer cells and bronchial epithelium of lung cancer patients

Histology and Histopathology

Volumn 25, Issue 6, 2010, Pages 755-764

  Mousa, Shaaban A ^a   Krajnik, Malgorzata ^b   Sobanski, Piotr ^c   Kowalewski, Janusz ^c   Bloch Boguslawska, Elzbieta ^c   Zylicz, Zbigniew ^d   Schäfer, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d Dove House Hospice   (United Kingdom)

Author keywords

Carboxypeptidase; Convertase; Lung; Opioid peptides; Opioid receptors

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CARBOXYPEPTIDASE H; DYNORPHIN; ENKEPHALIN; KAPPA OPIATE RECEPTOR; PREPROENKEPHALIN; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; PROTEIN PRECURSOR; TUMOR MARKER;

AGED; ARTICLE; BRONCHUS; CARCINOMA; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RESPIRATORY TRACT MUCOSA;

AGED; BRONCHI; CARBOXYPEPTIDASE H; CARCINOMA; DYNORPHINS; ENKEPHALINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; PROTEIN PRECURSORS; RECEPTORS, OPIOID, KAPPA; RESPIRATORY MUCOSA; TUMOR MARKERS, BIOLOGICAL;

EID: 77953443184     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Adriaensen D., Brouns I., Pintelon I., De Proost I. and Timmermans J.P. (2006). Evidence for a role of neuroepithelial bodies as complex airway sensors: comparison with smooth muscle-associated airway receptors. J. Appl. Physiol. 101, 960-970.
2. Barnes P.J. (1991). Neuropeptides and asthma. Am. Rev. Respir. Dis. 143, S28-32.
3. Belvisi M.G., Stretton C.D., Verleden G.M., Ledingham S.J., Yacoub M.H. and Barnes P.J. (1992). Inhibition of cholinergic neurotransmission in human airways by opioids. J. Appl. Physiol. 72, 1096-1100.
4. Berman Y., Mzhavia N., Polonskaia A., Furuta M., Steiner D.F., Pintar J.E. and Devi L.A. (2000). Defective prodynorphin processing in mice lacking prohormone convertase PC2. J. Neurochem. 75, 1763-1770.
5. Berman Y., Mzhavia N., Polonskaia A. and Devi L.A. (2001). Impaired prohormone convertases in Cpe(fat)/Cpe(fat) mice. J. Biol. Chem. 276, 1466-1473.
6. Bhargava H.N., Villar V.M., Cortijo J. and Morcillo E.J. (1997). Binding of [D-Ala2, MePhe4, Gly-ol5] enkephalin, [3H][D-Pen2, DPen5] enkephalin, and [3H]U-69,593 to airway and pulmonary tissues of normal and sensitized rats. Peptides 18, 1603-1608.
7. Bidlack J.M., Khimich M., Parkhill A.L., Sumagin S., Sun B. and Tipton C.M. (2006). Opioid receptors and signaling on cells from the immune system. J. Neuroimmune. Pharmacol. 1, 260-269.
8. Boudarine M., Yegorov O., Sterling-Dubrovsky A., Devi L.A. and Berman Y. (2002). Developmental changes in opioid peptides and their receptors in Cpe(fat)/Cpe(fat) mice lacking peptide processing enzyme carboxypeptidase E. J. Pharmacol. Exp. Ther. 303, 1317-1324.
9. Cabot P.J., Dodd P.R., Cramond T. and Smith M.T. (1994). Characterization of non-conventional opioid binding sites in rat and human lung. Eur. J. Pharmacol. 268, 247-255.
10. Carr D.J. and Blalock J.E. (1989). A molecular basis for intersystem communication between the immune and neuroendocrine systems. Int. Rev. Immunol. 4, 213-228.
11. + channels. Ann. N. Y. Acad. Sci. 540, 694-697.
12. Chavkin C., James I.F. and Goldstein A. (1982). Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215, 413-415.
13. Creemers J.W.M., Roebroek A.J.M. and Van de Ven W.J.M. (1992). Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3: Cloning and primary sequence of a 5 kb cDNA. FEBS Lett. 300, 82-88.
14. Cutz E., Chan W. and Track N.S. (1981). Bombesin, calcitonin and leuenkephalin immunoreactivity in endocrine cells of human lung. Experientia 37, 765-767.
15. Cutz E., Perrin D.G., Pan J., Haas E.A. and Krous H.F. (2007). Pulmonary neuroendocrine cells and neuroepithelial bodies in sudden infant death syndrome: potential markers of airway chemoreceptor dysfunction. Pediatr. Dev. Pathol. 10, 106-116.
16. Dupuy A., Lindberg I., Zhou Y., Akil H., Lazure C., Chrétien M., Seidah N.G. and Day R. (1994). Processing of prodynorphin by the prohormone convertase PC1 results in high molecular weight intermediate forms. Cleavage at a single arginine residue. FEBS Lett. 337, 60-65.
17. Geijer T.J., Bergh J. and Terenius L. (1991). Expression of preprodynorphin in human small cell lung carcinoma cell lines. Regul. Pept. 34, 181-188.
18. Hatzoglou A., Bakogeorgou E. and Castanas E. (1996). The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur. J. Pharmacol. 296, 199-207.
19. Haworth R., Woodfine J., McCawley S., Pilling A.M., Lewis D.J. and Williams T.C. (2007). Pulmonary neuroendocrine cell hyperplasia: identification, diagnostic criteria and incidence in untreated ageing rats of different strains. Toxicol. Pathol. 35, 735-740.
20. Horii S., Tamaoki J., Kanemura T., Yamawaki I. and Takizawa T. (1990). Effects of beta-endorphin and dynorphin A on cholinergic neurotransmission in canine airway smooth muscle. Eur. J. Pharmacol. 182, 497-502.
21. Ichinose M., Asai M. and Sawada M. (1995). Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages. J. Neuroimmunol. 60, 37-43.
22. Kamikawa Y. and Shimo Y. (1990). Morphine and opioid peptides selectively inhibit the non-cholinergically mediated neurogenic contraction of guinea-pig isolated bronchial muscle. J. Pharm. Pharmacol. 42, 214-216.
23. Kampa M., Loukas S., Hatzoglou A., Martin P., Martin P.M. and Castanas E. (1996). Identification of a novel opioid peptide (Tyr-Val- Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1- casomorphin, and alpha S1-casomorphin amide). Biochem. J. 319, 903-908.
24. Kummer W., Fischer A., Kurkowski R. and Heym C. (1992). The sensory and sympathetic innervation of guinea-pig lung and trachea as studied by retrograde neuronal tracing and double-labelling immunohistochemistry. Neuroscience 49, 715-737.
25. Kurkowski R., Kummer W. and Heym C. (1990). Substance Pimmunoreactive nerve fibers in tracheobronchial lymph nodes of the guinea pig: origin, ultrastructure and coexistence with other peptides. Peptides 11, 13-20.
26. Linnoila R.I. (2006). Functional facets of the pulmonary neuroendocrine system. Lab. Invest. 86, 425-444.
27. Machelska H., Schopohl J.K., Mousa S.A., Labuz D., Schäfer M. and Stein C. (2003). Different mechanisms of intrinsic pain inhibition in early and late inflammation. J. Neuroimmunol. 141, 30-39.
28. Maestroni G.J., Zammaretti F. and Pedrinis E. (1999). Hematopoietic effect of melatonin involvement of type 1 kappa-opioid receptor on bone marrow macrophages and interleukin-1. J. Pineal. Res. 27, 145-153.
29. Maneckjee R. and Minna J.D. (1990). Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. Natl. Acad. Sci. USA 87, 3294-3298.
30. Maneckjee R., Biswas R. and Vonderhaar B.K. (1990). Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res. 50, 2234-2238.
31. McLaughlin P.J., Levin R.J. and Zagon I.S. (1999). Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor. Int. J. Oncol. 14, 991-998.
32. Mibikay M., Sirois F., Seidah N.G. and Chretien M. (1997). Comparative analysis of expression of the prohormone convertases furin, PACE4, PC1, and PC2 in human lung tumors. Br. J. Cancer 75, 1509-1514.
33. Mousa S.A., Shakibaei M., Sitte N., Schäfer M. and Stein C. (2004). Subcellular pathways of ß-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 145, 1331-1341.
34. Mousa S.A., Straub R.H., Schäfer M. and Stein C. (2007a). Betaendorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann. Rheum. Dis. 66, 871-879.
35. Mousa S.A., Cheppudira B.P., Shaqura M., Fischer O., Hofmann J., Hellweg R., Schäfer M. (2007b). Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain 130, 502-513.
36. Murgo A.J. (1985). Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin. J. Natl. Cancer Inst. 75, 341-344.
37. North W.G. and Du J. (1998). Key peptide processing enzymes are expressed by a variant form of small-cell carcinoma of the lung. Peptides 19, 1743-1747.
38. Przewlocki R., Hassan A.H., Lason W., Epplen C., Herz A. and Stein C. (1992). Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 48, 491-500.
39. Rounseville M.P. and Davis T.P. (2000). Prohormone convertase and autocrine growth factor mPNAs are coexpressed in small cell lung carcinoma. J. Mol. Endocrinol. 25, 121-128.
40. Sacerdote P. (2003). Effects of in vitro and in vivo opioids on the production of IL-12 and IL-10 by murine macrophages. Ann. N.Y. Acad. Sci. 992, 129-140.
41. Sato H., Terasaki T. and Tsuji A. (1990). Specific binding and clearance of [3H]dynorphin (1-13) in the perfused rat lung: an application of the multiple-indicator dilution method. J. Pharm. Pharmacol. 42, 879-882.
42. Scholar E.M., Violi L. and Hexum T.D. (1987). The antimetastatic activity of enkephalin-like peptides. Cancer Lett. 35, 133-138.
43. Shimosegawa T., Foda H.D. and Said S.I. (1989). Immunohistochemical demonstration of enkephalin-containing nerve fibres in guinea pig and rat lungs. Am. Rev. Respir. Dis. 140, 441-448.
44. Sun B., Tipton C.M. and Bidlack J.M. (2006). The expression of prodynorphin gene is down-regulated by activation with lipopolysaccharide in U-937 macrophage cells. J. Neuroimmunol. 174, 52-62.
45. Tosk J.M., Grim J.R., Kinback K.M., Sale E.J., Bozzetti L.P. and Will A.D. (1993). Modulation of chemiluminescence in a murine macrophage cell line by neuroendocrine hormones. Int. J. Immunopharmacol. 15, 615-620.
46. Vujiç V., Stanojeviç S. and Dimitrijeviç M. (2004). Methionine-enkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophages: interaction of mu, delta and kappa opioid receptors. Neuroimmunomodulation 11, 392-403.
47. Wang L., Tiniakov R.L. and Yeates D.B. (2003). Peripheral opioid regulation of the tracheobronchial mucociliary transport system. J. Appl. Physiol. 94, 2375-2383.
48. Zagon I.S. and McLaughlin P.J. (1983a). Naltrexone modulates tumor response in mice with neuroblastoma. Science 221, 671-673.
49. Zagon I.S. and McLaughlin P.J. (1983b). Opioid antagonists inhibit the growth of metastatic murine neuroblastoma. Cancer Lett. 21, 89-94.
50. Zagon I.S. and McLaughlin P.J. (2005). Opioids and differentiation in human cancer cells. Neuropeptides 39, 495-505.
51. Zagon I.S., Rahn K.A., McLaughlin P.J. (2007). Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells. Neuropeptides 41, 441-452.